1935
Born in Tanta, Egypt to Mohamed Mohamed and Zeinab Hussein Amer.
1958
Immigrates to the United States.
1960
Receives a Master of Science in pharmacology from the University of Illinois at Chicago.
1962
Receives a Doctor of Philosophy in pharmacology from the University of Illinois at Chicago.
1966
Becomes a senior research pharmacologist and project coordinator at Wilson Laboratories, Inc.
1969
Becomes director of Cardiovascular Pharmacology at Mead Johnson & Co.
1971
Is an invited speaker at the International Conference on the Physiology and Pharmacology of Cyclic AMP in Milan, Italy, and at Prostaglandins in Cell Biology in Carmel, Virginia.
1972
Is an invited speaker at the Third American Peptide Symposium in Boston, Massachusetts.
1973
Is an invited speaker at “The Possible Role of Cyclic Nucleotides in the Control of Gastrointestinal Function” in Princeton, New Jersey, and at AMP Changes in Disease in New York, New York.
1974
Is an invited speaker at Cyclic Nucleotides in Disease in Philadelphia, Pennsylvania.
1976
Is an invited speaker at Cyclic Nucleotides Systems, “A Target for Drug Design” in London, England.
1977
Becomes director of Biological Research Responsible for all Pre-Clinical Work for Bristol-Myers International Division.
1977
Is an invited speaker at the Gastrointestinal Pharmacology Group Conference in Princeton, New Jersey.
1978
Is an invited speaker at Synthetic Cyclic Nucleotides and Therapeutics Perspectives in Paris, France.
1982
Receives a Master of Business Administration in business from Columbia University.
1983
Serves as president of Sam Amer & Co., Inc. in Santa Barbara, California.
1985
Co-founds Amstell, Inc., where he serves as president.
1986
Co-founds Top Laboratories, Inc., where he serves as president.
1989
Co-founds Amer Particle Technology, Inc., where he serves as president.